Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports

Fig. 1

Lab trends in relation to eculizumab initiation for both patients. a Trend of platelet count (B/L) and serum creatinine (mg/dL) during case 1 hospitalization, with note of day of eculizumab initiation. On eculizumab initiation, platelet count was 27 B/L and creatinine was 5.44 mg/dL. b Trend of platelet count (B/L) and serum creatinine (mg/dL) during case 2 hospitalization, with note of day of eculizumab initiation. On eculizumab initiation, platelet count was 84 B/L and creatinine was 4.25 mg/dL

Back to article page